Prognostic markers at baseline
Marker, result . | % . | Overall survival at 5 years, % . | P . |
|---|---|---|---|
| MIB 1 | |||
| 0-2+ | 56 | 38.6 | |
| 3-4+ | 44 | 41.0 | |
| MUC 1 | .5 | ||
| Neg | 64 | 39.2 | |
| Pos | 36 | 40.6 | |
| MDR | .6 | ||
| Neg | 40 | 34.5 | |
| Pos | 60 | 40.6 | |
| P53 | .6 | ||
| Neg | 83 | 39.5 | |
| Pos | 17 | 41.0 | |
| BCL 2 | .9 | ||
| Neg | 49 | 37.1 | |
| Pos | 51 | 42.2 |
Marker, result . | % . | Overall survival at 5 years, % . | P . |
|---|---|---|---|
| MIB 1 | |||
| 0-2+ | 56 | 38.6 | |
| 3-4+ | 44 | 41.0 | |
| MUC 1 | .5 | ||
| Neg | 64 | 39.2 | |
| Pos | 36 | 40.6 | |
| MDR | .6 | ||
| Neg | 40 | 34.5 | |
| Pos | 60 | 40.6 | |
| P53 | .6 | ||
| Neg | 83 | 39.5 | |
| Pos | 17 | 41.0 | |
| BCL 2 | .9 | ||
| Neg | 49 | 37.1 | |
| Pos | 51 | 42.2 |